$TRIV TriVascular Technologies, Inc. Insider Trading Week 16/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TriVascular Technologies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in TriVascular Technologies, Inc. in week 16/2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Option Exercise | C | 15.81 | 55,831 | 882,470 | 55,831 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Option Exercise | C | 0.00 | 55,831 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Option Exercise | C | 0.00 | 411,234 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Option Exercise | A | 0.00 | 411,234 | 0 | 411,234 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Option Exercise | C | 0.00 | 1,236,487 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Option Exercise | C | 0.00 | 531,758 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Option Exercise | C | 0.00 | 383,249 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Option Exercise | C | 0.00 | 797,208 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Buy | C | 0.00 | 411,234 | 0 | 3,943,269 | 3.5 M to 3.9 M (+11.64 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Buy | C | 0.00 | 1,236,487 | 0 | 3,532,035 | 2.3 M to 3.5 M (+53.86 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Buy | C | 0.00 | 531,758 | 0 | 2,295,548 | 1.8 M to 2.3 M (+30.15 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Buy | C | 0.00 | 383,249 | 0 | 1,763,790 | 1.4 M to 1.8 M (+27.76 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Buy | C | 0.00 | 797,208 | 0 | 1,380,541 | 583.3 K to 1.4 M (+136.66 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Buy | P | 12.00 | 583,333 | 6,999,996 | 583,333 | 0 to 583.3 K |
Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Option Exercise | C | 15.81 | 55,831 | 882,470 | 55,831 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Option Exercise | C | 0.00 | 55,831 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Option Exercise | C | 0.00 | 411,234 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Option Exercise | C | 0.00 | 1,236,487 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Option Exercise | C | 0.00 | 531,758 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Option Exercise | C | 0.00 | 383,249 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Option Exercise | C | 0.00 | 797,208 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Buy | C | 0.00 | 411,234 | 0 | 3,943,269 | 3.5 M to 3.9 M (+11.64 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Buy | C | 0.00 | 1,236,487 | 0 | 3,532,035 | 2.3 M to 3.5 M (+53.86 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Buy | C | 0.00 | 531,758 | 0 | 2,295,548 | 1.8 M to 2.3 M (+30.15 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Buy | C | 0.00 | 383,249 | 0 | 1,763,790 | 1.4 M to 1.8 M (+27.76 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Buy | C | 0.00 | 797,208 | 0 | 1,380,541 | 583.3 K to 1.4 M (+136.66 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Buy | P | 12.00 | 583,333 | 6,999,996 | 583,333 | 0 to 583.3 K |
Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Option Exercise | A | 8.93 | 4,929 | 44,016 | 4,929 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Option Exercise | C | 15.81 | 6,326 | 99,989 | 6,326 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Option Exercise | C | 0.00 | 6,326 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Option Exercise | C | 0.00 | 7,847 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Option Exercise | A | 0.00 | 7,847 | 0 | 7,847 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Option Exercise | C | 0.00 | 41,453 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Option Exercise | C | 0.00 | 17,725 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Option Exercise | C | 0.00 | 11,537 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Buy | C | 0.00 | 7,847 | 0 | 86,838 | 79 K to 86.8 K (+9.93 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Buy | C | 0.00 | 41,453 | 0 | 78,991 | 37.5 K to 79 K (+110.43 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Buy | C | 0.00 | 17,725 | 0 | 37,538 | 19.8 K to 37.5 K (+89.46 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Buy | C | 0.00 | 11,537 | 0 | 19,813 | 8.3 K to 19.8 K (+139.40 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Option Exercise | C | 15.81 | 45,094 | 712,760 | 45,094 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Option Exercise | C | 0.00 | 45,094 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Option Exercise | C | 0.00 | 347,965 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Option Exercise | A | 0.00 | 347,965 | 0 | 347,965 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Option Exercise | C | 0.00 | 970,167 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Option Exercise | C | 0.00 | 424,918 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Option Exercise | C | 0.00 | 384,594 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Option Exercise | C | 0.00 | 574,933 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Buy | C | 0.00 | 347,965 | 0 | 3,535,910 | 3.2 M to 3.5 M (+10.92 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Buy | C | 0.00 | 970,167 | 0 | 3,187,945 | 2.2 M to 3.2 M (+43.75 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Buy | C | 0.00 | 424,918 | 0 | 2,217,778 | 1.8 M to 2.2 M (+23.70 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Buy | C | 0.00 | 384,594 | 0 | 1,792,860 | 1.4 M to 1.8 M (+27.31 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Buy | C | 0.00 | 574,933 | 0 | 1,408,266 | 833.3 K to 1.4 M (+68.99 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Buy | P | 12.00 | 833,333 | 9,999,996 | 833,333 | 0 to 833.3 K |
Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Option Exercise | C | 15.81 | 45,094 | 712,760 | 45,094 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 45,094 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 347,965 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Option Exercise | A | 0.00 | 347,965 | 0 | 347,965 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 970,167 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 424,918 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 384,594 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 574,933 | 0 | 0 | |
Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Buy | C | 0.00 | 347,965 | 0 | 3,535,910 | 3.2 M to 3.5 M (+10.92 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Buy | C | 0.00 | 970,167 | 0 | 3,187,945 | 2.2 M to 3.2 M (+43.75 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Buy | C | 0.00 | 424,918 | 0 | 2,217,778 | 1.8 M to 2.2 M (+23.70 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Buy | C | 0.00 | 384,594 | 0 | 1,792,860 | 1.4 M to 1.8 M (+27.31 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Buy | C | 0.00 | 574,933 | 0 | 1,408,266 | 833.3 K to 1.4 M (+68.99 %) |
Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Buy | P | 12.00 | 833,333 | 9,999,996 | 833,333 | 0 to 833.3 K |
Apr 23 2014 | TRIV | TriVascular Techno ... | MPM BioVentures IV QP LP | 10% Owner | Option Exercise | C | 15.81 | 37,369 | 590,658 | 37,369 | |
Apr 23 2014 | TRIV | TriVascular Techno ... | MPM BioVentures IV QP LP | 10% Owner | Option Exercise | C | 0.39 | 1,516,122 | 590,681 | 0 | |
Apr 23 2014 | TRIV | TriVascular Techno ... | MPM BioVentures IV QP LP | 10% Owner | Option Exercise | C | 0.00 | 10,266,940 | 0 | 0 | |
Apr 23 2014 | TRIV | TriVascular Techno ... | MPM BioVentures IV QP LP | 10% Owner | Option Exercise | C | 0.00 | 15,400,411 | 0 | 0 | |
Apr 23 2014 | TRIV | TriVascular Techno ... | MPM BioVentures IV QP LP | 10% Owner | Option Exercise | C | 0.00 | 2,947,605 | 0 | 0 | |
Apr 23 2014 | TRIV | TriVascular Techno ... | MPM BioVentures IV QP LP | 10% Owner | Option Exercise | C | 0.00 | 6,000,000 | 0 | 0 | |
Apr 23 2014 | TRIV | TriVascular Techno ... | MPM BioVentures IV QP LP | 10% Owner | Option Exercise | C | 0.00 | 20,757,635 | 0 | 0 | |
Apr 23 2014 | TRIV | TriVascular Techno ... | MPM BioVentures IV QP LP | 10% Owner | Buy | C | 0.00 | 253,066 | 0 | 1,776,692 | 1.5 M to 1.8 M (+16.61 %) |
Apr 23 2014 | TRIV | TriVascular Techno ... | MPM BioVentures IV QP LP | 10% Owner | Buy | C | 0.00 | 379,599 | 0 | 1,523,626 | 1.1 M to 1.5 M (+33.18 %) |
Apr 23 2014 | TRIV | TriVascular Techno ... | MPM BioVentures IV QP LP | 10% Owner | Buy | C | 0.00 | 114,942 | 0 | 1,144,027 | 1 M to 1.1 M (+11.17 %) |
Apr 23 2014 | TRIV | TriVascular Techno ... | MPM BioVentures IV QP LP | 10% Owner | Buy | C | 0.00 | 230,756 | 0 | 1,029,085 | 798.3 K to 1 M (+28.90 %) |
Apr 23 2014 | TRIV | TriVascular Techno ... | MPM BioVentures IV QP LP | 10% Owner | Buy | C | 0.00 | 798,329 | 0 | 798,329 | 0 to 798.3 K |
Apr 23 2014 | TRIV | TriVascular Techno ... | Scopa James Paul | Director | Option Exercise | C | 15.81 | 37,369 | 590,658 | 37,369 | |
Apr 23 2014 | TRIV | TriVascular Techno ... | Scopa James Paul | Director | Option Exercise | C | 0.39 | 1,516,122 | 590,681 | 0 | |
Apr 23 2014 | TRIV | TriVascular Techno ... | Scopa James Paul | Director | Option Exercise | C | 0.00 | 10,266,940 | 0 | 0 | |
Apr 23 2014 | TRIV | TriVascular Techno ... | Scopa James Paul | Director | Option Exercise | A | 0.00 | 10,266,940 | 0 | 10,266,940 | |
Apr 23 2014 | TRIV | TriVascular Techno ... | Scopa James Paul | Director | Option Exercise | C | 0.00 | 15,400,411 | 0 | 0 | |
Apr 23 2014 | TRIV | TriVascular Techno ... | Scopa James Paul | Director | Option Exercise | C | 0.00 | 2,947,605 | 0 | 0 | |
Apr 23 2014 | TRIV | TriVascular Techno ... | Scopa James Paul | Director | Option Exercise | C | 0.00 | 6,000,000 | 0 | 0 | |
Apr 23 2014 | TRIV | TriVascular Techno ... | Scopa James Paul | Director | Option Exercise | C | 0.00 | 20,757,635 | 0 | 0 | |
Apr 23 2014 | TRIV | TriVascular Techno ... | Scopa James Paul | Director | Buy | C | 0.00 | 253,066 | 0 | 1,776,692 | 1.5 M to 1.8 M (+16.61 %) |
Apr 23 2014 | TRIV | TriVascular Techno ... | Scopa James Paul | Director | Buy | C | 0.00 | 379,599 | 0 | 1,523,626 | 1.1 M to 1.5 M (+33.18 %) |
Apr 23 2014 | TRIV | TriVascular Techno ... | Scopa James Paul | Director | Buy | C | 0.00 | 114,942 | 0 | 1,144,027 | 1 M to 1.1 M (+11.17 %) |
Apr 23 2014 | TRIV | TriVascular Techno ... | Scopa James Paul | Director | Buy | C | 0.00 | 230,756 | 0 | 1,029,085 | 798.3 K to 1 M (+28.90 %) |
Apr 23 2014 | TRIV | TriVascular Techno ... | Scopa James Paul | Director | Buy | C | 0.00 | 798,329 | 0 | 798,329 | 0 to 798.3 K |
Apr 22 2014 | TRIV | TriVascular Techno ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 253,384 | 0 | 0 | |
Apr 22 2014 | TRIV | TriVascular Techno ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 221,118 | 0 | 0 | |
Apr 22 2014 | TRIV | TriVascular Techno ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 71,333 | 0 | 0 | |
Apr 22 2014 | TRIV | TriVascular Techno ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 86,834 | 0 | 0 | |
Apr 22 2014 | TRIV | TriVascular Techno ... | Flynn James E | 10% Owner | Buy | P | 11.97 | 75,480 | 903,126 | 261,143 | 185.7 K to 261.1 K (+40.65 %) |
Apr 22 2014 | TRIV | TriVascular Techno ... | Flynn James E | 10% Owner | Buy | P | 11.97 | 94,520 | 1,130,941 | 324,524 | 230 K to 324.5 K (+41.09 %) |
Apr 22 2014 | TRIV | TriVascular Techno ... | Flynn James E | 10% Owner | Buy | P | 12.29 | 19,980 | 245,468 | 185,663 | 165.7 K to 185.7 K (+12.06 %) |
Apr 22 2014 | TRIV | TriVascular Techno ... | Flynn James E | 10% Owner | Buy | P | 12.29 | 25,020 | 307,388 | 230,004 | 205 K to 230 K (+12.21 %) |
Apr 22 2014 | TRIV | TriVascular Techno ... | Flynn James E | 10% Owner | Buy | P | 12.00 | 340,425 | 4,085,100 | 593,809 | 253.4 K to 593.8 K (+134.35 %) |
Apr 22 2014 | TRIV | TriVascular Techno ... | Flynn James E | 10% Owner | Buy | P | 12.00 | 297,075 | 3,564,900 | 518,193 | 221.1 K to 518.2 K (+134.35 %) |
Apr 22 2014 | TRIV | TriVascular Techno ... | Flynn James E | 10% Owner | Buy | P | 12.00 | 94,350 | 1,132,200 | 165,683 | 71.3 K to 165.7 K (+132.27 %) |
Apr 22 2014 | TRIV | TriVascular Techno ... | Flynn James E | 10% Owner | Buy | P | 12.00 | 118,150 | 1,417,800 | 204,984 | 86.8 K to 205 K (+136.06 %) |
Apr 22 2014 | TRIV | TriVascular Techno ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 253,384 | 0 | 253,384 | 0 to 253.4 K |
Apr 22 2014 | TRIV | TriVascular Techno ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 221,118 | 0 | 221,118 | 0 to 221.1 K |
Apr 22 2014 | TRIV | TriVascular Techno ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 71,333 | 0 | 71,333 | 0 to 71.3 K |
Apr 22 2014 | TRIV | TriVascular Techno ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 86,834 | 0 | 86,834 | 0 to 86.8 K |